History
Afalaza is developed - a product for improving common urinary tract problems in men
The start of commercial production of Rengalin -
an innovative product for treating dry and productive cough
The start of commercial production of Divaza - a product for treating chronic cerebrovascular disease
The in-house R&D laboratory is opened
for protection and strength of cardiac muscle.
Cardio
symptoms of giving -up smoking
10 years of confidence in Anaferon kids
Anaferon kids is the most
prescribed medicine
for children*.
* According to Comcon-Pharma data for 2012
GMP certificates
Materia Medica obtained certificates from State administration of Ukraine on Medicinal Products (SAUMP) and Slovakia State Institute for Drug control (SIDC)
Impaza’s 10th anniversary
Impaza is the most known brand in its category on Russian market **
** According to Comcon-Pharma data for 2012
medicine for weight loss.
Production expansion and launch of vitamin-mineral supplements
Multifort and Multifort kids (dietary supplement)
Launch
of Tenoten kids
Tenoten kids is the only sedative medicine developed especially for children in accordance with children constitution features.
kids
Changes in registration status
of Anaferon and Anaferon kids
The medical community officially recognized that Anaferon and Anaferon kids are medicinal products and no more homeopathic ones.
The manufactory in Tchelyabinsk opened new workshops and expanded production
New hi-tech equipement from Italy and Germany enables to unify full production cycle of solid dosage forms.
for development of new class of medicines.
for treatment of prostate adenoma and chronic prostatitis.
for alleviating symptoms of anxiety and stress.
for treatment of joint diseases.
The company introduced
Anaferon kids and Anaferon
Safe treatment and effective prophylaxis of flu and acute viral respiratory infections. Anaferon kids is specially developed for kids’ age.
Anaferon
kids
of alcoholic dependence.
100
Discovery of phenomenons of overdilute solutions
The company started intensive multi-centre clinical trials and developments of the new class of medicines based on ultra-low doses of antibodies to endogenous regulators.
–
1999
At the end of nineties the company’s portfolio included 10 homeopathic medicines of different pharmacological groups
Owing to combination of high safety profile and efficacy, homeopathic medicines quickly gained doctors’ and patients’ confidence.
First in Russia
mass production of
homeopathic medicines
Established in 1992 Materia Medica Holding launched first in Russia mass production of homeopathic medicines and made it available for a wide range of customers.